BlackRock Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

BlackRock Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.58M	Buy	87,943 +403	+0.5%	+$12.3K	﹤0.01%	2048
2016 Q3	$2.53M	Sell	87,540 -6,190	-7%	-$172K	﹤0.01%	1962
2016 Q2	$2.43M	Buy	93,730 +3,472	+4%	+$92.2K	﹤0.01%	1957
2016 Q1	$2.24M	Buy	90,258 +1,324	+1%	+$36.3K	﹤0.01%	1919
2015 Q4	$3.13M	Buy	88,934 +53	+0.1%	+$1.42K	﹤0.01%	1745
2015 Q3	$1.88M	Sell	88,881 -59	-0.1%	-$1.52K	﹤0.01%	2115
2015 Q2	$2.47M	Buy	88,940 +13,587	+18%	+$383K	﹤0.01%	2057
2015 Q1	$2.3M	Buy	75,353 +1,057	+1%	+$33.6K	﹤0.01%	1922
2014 Q4	$2.38M	Buy	74,296 +15,389	+26%	+$501K	﹤0.01%	1902
2014 Q3	$1.67M	Buy	58,907 +12	+0%	+$335	﹤0.01%	2132
2014 Q2	$1.61M	Buy	58,895 +12,376	+27%	+$329K	﹤0.01%	2257
2014 Q1	$1.23M	Buy	46,519 +200	+0.4%	+$5.74K	﹤0.01%	2367
2013 Q4	$1.36M	Sell	46,319 -864	-2%	-$27.4K	﹤0.01%	2286
2013 Q3	$1.44M	Buy	47,183 +3,096	+7%	+$104K	﹤0.01%	2179
2013 Q2	$1.4M	Buy	+44,087	New	+$1.45M	﹤0.01%	2133

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock Investment Management's GHDX Position: Q4 2016 in Review

BlackRock Investment Management increased its Genomic Health, Inc. (GHDX) stake by 0.46% in Q4 2016, buying an estimated $12.3K and bringing the position to 87,943 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2048.

BlackRock Investment Management first reported a position in GHDX in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.13M in Q4 2015. 133 funds tracked by Wall St. Rank hold GHDX as of Q4 2016.

BlackRock Investment Management held 87,943 shares of Genomic Health, Inc. worth $2.58M as of Q4 2016.
BlackRock Investment Management bought 403 Genomic Health, Inc. shares in Q4 2016, an estimated $12.3K.
Genomic Health, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2048 holding.
BlackRock Investment Management first reported a position in Genomic Health, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Genomic Health, Inc. position peaked at $3.13M in Q4 2015.
133 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.